569.83MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4923271013
CUSIP
492327101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
17.97
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.17
Wall Street Target Price
30.70
EPS Estimate Current Year
0.26
EPS Estimate Next Year
-4.44
EPS Estimate Current Quarter
0.0075
EPS Estimate Next Quarter
-1.105
Most Recent Quarter
-
Revenue TTM
214,712,992
Gross Profit TTM
204,262,000
EBITDA
-9,014,000
Profit Margin
1.96%
Return On Assets TTM
-1.01%
Return On Equity TTM
0.71%
Revenue Per Share TTM
5.554
Qtly Revenue Growth YOY
254413.30%
Diluted Eps TTM
-0.17
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
51
Price Sales TTM
2.6615
Price Book MRQ
0.784
Enterprise Value Revenue
6490
Enterprise Value EBITDA
-13
161.19
10.03%595.00
2.04%88.72
1.94%77.61
1.25%228.38
1.19%285.20
0.71%435.01
0.25%561.16
0.07%562.00
0.00%168.65
-1.23%